Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer
Clinical trial NCT01104571 · UNKNOWN
Trial details
- NCT number
- NCT01104571
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2017-08-30
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.